Absence of DA1/DA2 dopamine receptor interactions in proximal tubules of spontaneously hypertensive rats

American Journal of Physiology

Volumn 270, Issue 1 PART 2, 1996, Pages

  Vachvanichsanong, Prayong ^a   Sela, Shifra ^a   Sidhu, Anita ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FENOLDOPAM; SULPIRIDE; QUINPIROLE;

AFFINITY LABELING; ANIMAL; ARTICLE; BINDING COMPETITION; BINDING SITE; DRUG EFFECT; HYPERTENSION; KIDNEY PROXIMAL TUBULE; LIGHT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STEREOISOMERISM; WISTAR KYOTO RAT; ANIMAL MODEL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

AFFINITY LABELS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FENOLDOPAM; HYPERTENSION; KIDNEY TUBULES, PROXIMAL; LIGHT; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STEREOISOMERISM; SULPIRIDE;

EID: 0029691322     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.270.1.f98     Document Type: Article

References (32)

1. Aperia, A., U. Holtback, M. L. Syren, L. B. Svensson, J. Fryckstedt, and P. Greengard. Activation/deactivation of renal Na+,K+-ATPase: a final common pathway for regulation of natriuresis. FASEB J. 8: 436-439,1994.
2. Bertorello, A., and A. Aperia. Both DA! and DA2 receptor agonists are necessary to inhibit Na+-K+-ATPase activity in proximal tubules from rat kidney. Acta Physiol. Scand. 132: 441-443,1988.
3. Bertorello, A., and A. Aperia. Na+-K-ATPase is an effector protein for protein kinase C in renal proximal tubule cells. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F370-F373, 1989.
4. Bertorello, A., J. Hopfield, A. Aperia, and P. Greengard. Inhibition by dopamine of Na ' -K+-ATPase activity in neostriatal neurons through DI and D2 receptor synergism. Nature Land. 347: 386-388,1990.
5. Chen, C. J., and M. P. Lokhandwala. An impairment of renal tubular DAi receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin. Exp. Hypertens. 14: 615-628, 1992.
6. Chen, C. J., S. J. Vyas, J. Eichberg, R. E. Beach, and M. F. Lokhandwala. Abolished dopamine-1 receptor mediated inhibition of renal tubular Na+,K+-ATPase activity in spontaneously hypertensive rats. In: Genetic Hypertension, edited by J. Sassard. Paris: John Libbey, 1992, vol. 218, p. 463-465.
7. Felder, C. C., P. A. Jose, and J. Axelrod. The dopamine-1 agonist, SKF-82526, stimulates phospholipase C activity independent of adenylate cyclase. J. Pharmacol. Exp. Ther. 248: 171175, 1989.
8. Gurich, R. W., and R. E. Beach. Abnormal regulation of renal proximal tubule Na-K-ATPase by G proteins in spontaneously hypertensive rats. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F1069-F1075, 1994.
9. Horiuchi, A., F., E. Albrecht, G. M. Eisner, P. A. José, and R. A. Felder. Renal dopamine receptors and pre- and post-cAMPmediated Na transport defect in spontaneously hypertensive rats. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F1105-F1111, 1992.
10. Jadhav, A. L., and Q. Liu. DAI receptor mediated regulation of Na+-H+ antiport activity in rat renal cortical brush border membrane vesicles. Clin. Exp. Hypertens. 14: 653-666,1992.
11. Jarvie, K., R., G. Booth, E. M. Brown, and H. B. Niznik. Glycoprotein nature of dopamine Dl receptors in the brain and parathyroid gland. Mol. Pharmacol. 36: 566-574,1989.
12. Kebabian, J. W., and D. B. Calne. Multiple receptors for dopamine. Nature bond. 277: 93-96, 1979.
13. Kimura, K., S. Sela, C. Bouvier, D. K. Grandy, and A. Sidhu. Differential coupling of DI and D-5 dopamine receptors to guanine nucleotide binding proteins in transfected GH4Ci rat somatomammotrophic cells. J. Neurochem. 64: 2118-2124, 1995.
14. Kimura, K., B. White, and A. Sidhu. Coupling of human DI dopamine receptors to different guanine nucleotide binding proteins: evidence that DI dopamine receptors can couple to both Gs and G. J. Biol. Chem. 270: 14672-14672, 1995.
15. Kinoshita, S., A. Sidhu, and R. A. Felder. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubules from the spontaneously hypertensive rat. J. Clin. Invest. 84: 1849-1856,1989.
16. Kuchel, O., K. Racz, W. Debinski, P. Falardeau, and N. T. Buu. Contrasting dopaminergic patterns in two forms of genetic hypertension. Clin. Exp. Hypertens. A9: 987-1008,1987.
17. Lokhandwala, M. F., and F. Amenta. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J. 5: 3023-3030,1991.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
19. Mordachowicz, G. A., H. D. Sheikh, O. D. Jo, E. P. Nord, D. B. Lee, and N. Yanagawa. Increased Na/H antiport activity in the renal brush border membrane of SHR. Kidney Int. 36: 576-581,1989.
20. Munson, P., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107: 220-239, 1980.
21. Niznik, H. B., K. R. Jarvie, N. H. Bzowej, P. Seeman, R. K. Garlick, J. J. Miller, N. Baindur, and J. L. Neumeyer. Photoaffinity labeling of dopamine Dl receptors. Biochemistry 27: 7594-7599,1988.
22. Piomelli, D., C. Pilon, B. Giros, P. Sokoloff, M.-P. Martes, and J.-C. Schwartz. Dopamine activation of the arachidonic acid cascade as a basis for ~Di/D2 synergism. Nature Land. 353: 164-167, 1991.
23. Robles, R. G., E. Villa, J. Martinez, L. M. Ruilope, and J. M. Sancho. Natriuretic effects of dopamine agonist drugs in models of reduced renal mass. J. Cardiovasc. Pharmacol. 22, Suppl. 2: 88-92, 1993.
24. Seeman, P., H. B. Niznik, H.-C. Guan, G. Booth, and C. Ulpian. Link between DI and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc. Natl.Acad.Sci. USA 86: 10156-10160, 1989.
25. Shiekhamad, D., O. D. Jo, N. Yanagawa, and D. B. Lee. Sodium (Na) transport by isolated renal brush border membrane vesicles (BBMV) from spontaneously hypertensive rats (SHR): increased Na/H countertransport (CT) (Abstract). Kidney Int. 31: 390, 1987.
26. Shusterman, N. H., W. J. Elliott, and W. B. White. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am. J. Med. 95: 161-168, 1993.
27. Sidhu, A., R. A. Felder, P. A., Jose, and P. H. Fishman. Comparison of the central and renal dopamine-1 receptor. Am. J. Hypertens. 3: 37S-39S, 1990.
28. Sidhu, A., K. Kimura, and P. Vachvanichsanong. Induction of G protein-independent agonist high-affinity binding sites of DI dopamine receptors by -mercaptoethanol. Biochemistry 33: 11246-11253, 1994.
29. Sidhu, A., P. Vachvanichsanong, P. A. Jose, and R. Felder. Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats. J. Clin. Invest. 89: 789-793, 1992.
30. Sidhu, A., J. van Oene, P. Dandridge, C. Kaiser, and J. W. Kebabian. |125I]SCH 23982: the ligand of choice for identifying the D, dopamine receptor. Eur. J. Pharmacol. 128: 213-220, 1986.
31. Sugamori, K. S., L. L. Demchyshyn, M. Chung, and H. B. Niznik. D1A, DIB, and DIG dopamine receptors from Xenopus laevis. Proc. Natl. Acad. Sei. USA 91: 10536-10540, 1994.
32. Vachvanichsanong, P., K. Kimura, and A. Sidhu. Differences in photoaffinity labeling of DAi dopamine receptors in renal proximal tubules from normotensive and SHR. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F1009-F1016, 1995.